• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

140
17
14
14
10

COUNTRY

14
3
2
1
1

PRICE

90
149
251
391

PUBLISHED

2
11
69
391

PRODUCT TYPE

377
10
4

Respiratory

Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

PRODUCT TITLE

Pharyngitis - Pipeline Review, H1 2013

Pharyngitis - Pipeline Review, H1 2013 Summary 'Pharyngitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the...

June 2013
FROM

Malignant Pleural Effusion - Pipeline Review, H1 2013

Malignant Pleural Effusion - Pipeline Review, H1 2013 Summary 'Malignant Pleural Effusion - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

June 2013
FROM

Seasonal Allergic Rhinitis - Pipeline Review, H1 2013

'Seasonal Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Seasonal Allergic...

June 2013
FROM

Emphysema - Pipeline Review, H1 2013

Emphysema – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Emphysema - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

May 2013
FROM

EpiCast Report: Asthma - Epidemiology Forecast to 2022

EpiCast Report: Asthma - Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004...

May 2013
FROM

Bronchiolitis Obliterans - Pipeline Review, H1 2013

Bronchiolitis Obliterans – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bronchiolitis Obliterans - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM

Acute Lung Injury - Pipeline Review, H1 2013

Acute Lung Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Lung Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Allergic Asthma - Pipeline Review, H1 2013

Allergic Asthma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Allergic Asthma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Pulmonary Fibrosis - Pipeline Review, H1 2013

Pulmonary Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

Respiratory Distress Syndrome - Pipeline Review, H1 2013

Respiratory Distress Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Respiratory Distress Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

May 2013
FROM

Respiratory Tract Infections - Pipeline Review, H1 2013

Respiratory Tract Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Respiratory Tract Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

May 2013
FROM

Lung Injury - Pipeline Review, H1 2013

Lung Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lung Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Pediatric Respiratory Syncytial...

April 2013
FROM
Sleep Apnea - Pipeline Review, H1 2013 Sleep Apnea - Pipeline Review, H1 2013 - Product Thumbnail Image

Sleep Apnea - Pipeline Review, H1 2013

Sleep Apnea – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sleep Apnea - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia...

April 2013
FROM

Lung Injury Global Clinical Trials Review, H1, 2013

Lung Injury Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2013" provides data on the Lung Injury clinical trial scenario...

April 2013
FROM

Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022

Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Synagis (Pediatric RSV) - Forecast and Market Analysis to...

April 2013
FROM

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2013" provides data on the...

April 2013
FROM

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2013" provides data...

April 2013
FROM

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick,...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos